Clinical Manifestations and Diagnostic Considerations in Parry-Romberg Syndrome and Localized Craniofacial Scleroderma

Distribution Patterns and Diagnostic Tools

• The segmental distribution in both Parry-Romberg Syndrome (PRS) and Localized Craniofacial Scleroderma (LCS) follows specific developmental facial units that have been mapped into distinct patterns: frontotemporal, maxillary, mandibular, and frontonasal 1
• Patients with PRS involving face and head should undergo MRI of the head at diagnosis due to potential neurological involvement 2, 3
• Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) is recommended to assess disease activity and extent in these conditions, as suggested by the European League Against Rheumatism 2, 4
• MRI is recommended for patients with facial and head involvement to assess for neurological complications, according to the American College of Rheumatology 2, 3
• Patients with facial involvement should undergo comprehensive evaluation including ophthalmological assessment and maxillofacial examination, as recommended by the American Academy of Dermatology 2, 3

Clinical Implications and Monitoring Strategies

• The specific pattern of involvement may predict potential complications and guide monitoring strategies, with a moderate level of evidence supporting this approach 2